Plasma renin activity for predicting antihypertensive drug efficacy.
Blumenfeld
Jon D
JD
D000284:Administration, Oral; D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D001565:Benzoates / Q000008:administration & dosage / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D001713:Biphenyl Compounds; D044383:Black People; D001794:Blood Pressure / Q000187:drug effects*; D018660:Blood Pressure Monitoring, Ambulatory; D001835:Body Weight; D004334:Drug Administration Schedule; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy* / Q000208:ethnology / Q000503:physiopathology; D018579:Patient Selection; D012083:Renin / Q000097:blood*; D012107:Research Design; D012737:Sex Factors; D000077333:Telmisartan; D013777:Tetrazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D044465:White People
D047228:Angiotensin II Type 1 Receptor Blockers; D001562:Benzimidazoles; D001565:Benzoates; D015415:Biomarkers; D001713:Biphenyl Compounds; D013777:Tetrazoles; D012083:Renin; C081643:candesartan; D000077333:Telmisartan